204 related articles for article (PubMed ID: 23300138)
1. A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
He M; Wu C; Xu J; Guo H; Yang H; Zhang X; Sun J; Yu D; Zhou L; Peng T; He Y; Gao Y; Yuan J; Deng Q; Dai X; Tan A; Feng Y; Zhang H; Min X; Yang X; Zhu J; Zhai K; Chang J; Qin X; Tan W; Hu Y; Lang M; Tao S; Li Y; Li Y; Feng J; Li D; Kim ST; Zhang S; Zhang H; Zheng SL; Gui L; Wang Y; Wei S; Wang F; Fang W; Liang Y; Zhai Y; Chen W; Miao X; Zhou G; Hu FB; Lin D; Mo Z; Wu T
Gut; 2014 Jan; 63(1):143-51. PubMed ID: 23300138
[TBL] [Abstract][Full Text] [Related]
2. Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer.
Abe T; Koi C; Kohi S; Song KB; Tamura K; Macgregor-Das A; Kitaoka N; Chuidian M; Ford M; Dbouk M; Borges M; He J; Burkhart R; Wolfgang CL; Klein AP; Eshleman JR; Hruban RH; Canto MI; Goggins M
Clin Gastroenterol Hepatol; 2020 May; 18(5):1161-1169.e5. PubMed ID: 31676359
[TBL] [Abstract][Full Text] [Related]
3. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
Yang J; Tang A; Ma J; Sun X; Ming L
Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
5. Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.
Luo G; Liu C; Guo M; Cheng H; Lu Y; Jin K; Liu L; Long J; Xu J; Lu R; Ni Q; Yu X
Ann Surg; 2017 Apr; 265(4):800-805. PubMed ID: 28267695
[TBL] [Abstract][Full Text] [Related]
6. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
9. A new discovery of STAT4 single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Chinese Han population: a case-control study.
Chao X; Wu J; Zhang W; Feng X; Zhao L; Huang F; Jiang C
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100914
[TBL] [Abstract][Full Text] [Related]
10. Role of CA 19.9 and CEA in predicting diagnosis in hepatocellular carcinoma.
Verma N; Vinocha A
J Cancer Res Ther; 2023; 19(5):1356-1358. PubMed ID: 37787308
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Tsuji M; Kashihara T; Terada N; Mori H
Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study of serum tumor markers in Southern Chinese Han population.
Li X; Bai F; Wei X; Jin T; Li C; Zhang Y; Lin M; Zhou X; Xie Y; He C; Lin Q; He P; Chu S; Ding Y
BMC Cancer; 2022 Feb; 22(1):160. PubMed ID: 35144566
[TBL] [Abstract][Full Text] [Related]
13. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
Xu F; Zhang L; He W; Song D; Ji X; Shao J
Dis Markers; 2021; 2021():8868370. PubMed ID: 33628341
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate Antigen 19-9 Increases the Predictive Efficiency of α-Fetoprotein for Prognosis of Resected Hepatocellular Carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Am Surg; 2018 Jan; 84(1):80-85. PubMed ID: 29428032
[TBL] [Abstract][Full Text] [Related]
16. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.
Huang YL; Wu JR; Fang M; Zhao HL; Liu ZM; Ye J; Huang LS; Zhu B
Medicine (Baltimore); 2019 Apr; 98(14):e15090. PubMed ID: 30946366
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455
[TBL] [Abstract][Full Text] [Related]
18. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
Zhang S; Zhao Y; He L; Bo C; An Y; Li N; Ma W; Guo Y; Guo Y; Zhang C
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101851. PubMed ID: 34923180
[TBL] [Abstract][Full Text] [Related]
19. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Lopez JB; Balasegaram M; Timor J; Thambyrajah V
Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
Tsai CY; Liu KH; Chiu CT; Hsueh SW; Hung CY; Hsu JT; Tsang NM; Hung YS; Chou WC
Anticancer Res; 2021 May; 41(5):2711-2718. PubMed ID: 33952502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]